Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial

<strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-...

Full description

Bibliographic Details
Main Authors: Stefano Leo, Vladimir Lazarevic, Myriam Girard, Nadia Gaïa, Jacques Schrenzel, Victoire de Lastours, Bruno Fantin, Marc Bonten, Yehuda Carmeli, Emilie Rondinaud, Stephan Harbarth, Benedikt D. Huttner
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/8/6/941
id doaj-08c55ab4f5714d9fa8f01af6a473456e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Stefano Leo
Vladimir Lazarevic
Myriam Girard
Nadia Gaïa
Jacques Schrenzel
Victoire de Lastours
Bruno Fantin
Marc Bonten
Yehuda Carmeli
Emilie Rondinaud
Stephan Harbarth
Benedikt D. Huttner
spellingShingle Stefano Leo
Vladimir Lazarevic
Myriam Girard
Nadia Gaïa
Jacques Schrenzel
Victoire de Lastours
Bruno Fantin
Marc Bonten
Yehuda Carmeli
Emilie Rondinaud
Stephan Harbarth
Benedikt D. Huttner
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
Microorganisms
Fecal microbiota transplantation
extended-spectrum beta-lactamase-producing Enterobacteriaceae
carbapenemase-producing Enterobacteriaceae
microbiome
whole metagenome shotgun sequencing
author_facet Stefano Leo
Vladimir Lazarevic
Myriam Girard
Nadia Gaïa
Jacques Schrenzel
Victoire de Lastours
Bruno Fantin
Marc Bonten
Yehuda Carmeli
Emilie Rondinaud
Stephan Harbarth
Benedikt D. Huttner
author_sort Stefano Leo
title Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
title_short Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
title_full Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
title_fullStr Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
title_full_unstemmed Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial
title_sort metagenomic characterization of gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation: results from a multicenter randomized trial
publisher MDPI AG
series Microorganisms
issn 2076-2607
publishDate 2020-06-01
description <strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Here, we characterized the temporal dynamics of fecal microbiota changes in a sub-cohort of the R-GNOSIS WP3 participants before and after antibiotics/FMT using whole metagenome shotgun sequencing. <strong>Methods:</strong> We sequenced fecal DNA obtained from 16 ESBL-E/CPE carriers having received oral colistin/neomycin followed by FMT and their corresponding seven donors. Ten treatment-naïve controls from the same trial were included. Fecal samples were collected at baseline (V0), after antibiotics but before FMT (V2) and three times after FMT (V3, V4 and V5). <strong>Results:</strong> Antibiotic treatment transiently decreased species richness and diversity and increased the abundance of antibiotic resistance determinants (ARDs). <em>Bifidobacterium</em> species, together with butyrate- and propionate-producing species from Lachnospiraceae and Ruminococcaceae families were significantly enriched in post-FMT microbiota of treated carriers. After FMT, the proportion of Enterobacteriaceae was lower compared to baseline but without statistical significance. <strong>Conclusions:</strong> Combined antibiotic and FMT treatment resulted in enrichment of species that are likely to limit the gut colonization by ESBL-E/CPE.
topic Fecal microbiota transplantation
extended-spectrum beta-lactamase-producing Enterobacteriaceae
carbapenemase-producing Enterobacteriaceae
microbiome
whole metagenome shotgun sequencing
url https://www.mdpi.com/2076-2607/8/6/941
work_keys_str_mv AT stefanoleo metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT vladimirlazarevic metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT myriamgirard metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT nadiagaia metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT jacquesschrenzel metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT victoiredelastours metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT brunofantin metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT marcbonten metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT yehudacarmeli metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT emilierondinaud metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT stephanharbarth metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
AT benediktdhuttner metagenomiccharacterizationofgutmicrobiotaofcarriersofextendedspectrumbetalactamaseorcarbapenemaseproducingenterobacteriaceaefollowingtreatmentwithoralantibioticsandfecalmicrobiotatransplantationresultsfromamulticenterrandomizedtrial
_version_ 1724478057030352896
spelling doaj-08c55ab4f5714d9fa8f01af6a473456e2020-11-25T03:53:25ZengMDPI AGMicroorganisms2076-26072020-06-01894194110.3390/microorganisms8060941Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized TrialStefano Leo0Vladimir Lazarevic1Myriam Girard2Nadia Gaïa3Jacques Schrenzel4Victoire de Lastours5Bruno Fantin6Marc Bonten7Yehuda Carmeli8Emilie Rondinaud9Stephan Harbarth10Benedikt D. Huttner11Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandGenomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Rue Michel Servet 1, 1211 Geneva, SwitzerlandDivision of Internal Medicine, Beaujon Hospital, APHP, Boulevard du Général Leclerc 100, 92110 Clichy, FranceDivision of Internal Medicine, Beaujon Hospital, APHP, Boulevard du Général Leclerc 100, 92110 Clichy, FranceDepartment of Medical Microbiology, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, The NetherlandsNational Institute for Antibiotic Resistance and Infection Control, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Weizmann Street 6, 6423906 Tel Aviv, IsraelDepartment of Medical Microbiology, APHP, Bichat-Claude-Bernard Hospital, Rue Henri Huchard 46, 75018 Paris, FranceDivision of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, SwitzerlandDivision of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland<strong>Background:</strong> The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) WP3 study was the first multicenter randomized clinical trial systematically investigating fecal microbiota transplantation (FMT) for intestinal decolonization of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Here, we characterized the temporal dynamics of fecal microbiota changes in a sub-cohort of the R-GNOSIS WP3 participants before and after antibiotics/FMT using whole metagenome shotgun sequencing. <strong>Methods:</strong> We sequenced fecal DNA obtained from 16 ESBL-E/CPE carriers having received oral colistin/neomycin followed by FMT and their corresponding seven donors. Ten treatment-naïve controls from the same trial were included. Fecal samples were collected at baseline (V0), after antibiotics but before FMT (V2) and three times after FMT (V3, V4 and V5). <strong>Results:</strong> Antibiotic treatment transiently decreased species richness and diversity and increased the abundance of antibiotic resistance determinants (ARDs). <em>Bifidobacterium</em> species, together with butyrate- and propionate-producing species from Lachnospiraceae and Ruminococcaceae families were significantly enriched in post-FMT microbiota of treated carriers. After FMT, the proportion of Enterobacteriaceae was lower compared to baseline but without statistical significance. <strong>Conclusions:</strong> Combined antibiotic and FMT treatment resulted in enrichment of species that are likely to limit the gut colonization by ESBL-E/CPE.https://www.mdpi.com/2076-2607/8/6/941Fecal microbiota transplantationextended-spectrum beta-lactamase-producing Enterobacteriaceaecarbapenemase-producing Enterobacteriaceaemicrobiomewhole metagenome shotgun sequencing